Helius Medical Technologies Inc (TSE:HSM) Expected to Earn FY2019 Earnings of ($1.17) Per Share

Share on StockTwits

Helius Medical Technologies Inc (TSE:HSM) – Equities researchers at Oppenheimer lifted their FY2019 earnings estimates for Helius Medical Technologies in a note issued to investors on Tuesday, November 12th. Oppenheimer analyst S. Lichtman now anticipates that the company will earn ($1.17) per share for the year, up from their previous estimate of ($1.18). Oppenheimer also issued estimates for Helius Medical Technologies’ FY2020 earnings at ($1.27) EPS and FY2021 earnings at ($1.18) EPS.

Shares of TSE HSM opened at C$1.10 on Friday. Helius Medical Technologies has a twelve month low of C$1.08 and a twelve month high of C$14.16. The company has a current ratio of 3.40, a quick ratio of 3.15 and a debt-to-equity ratio of 5.56. The company has a market capitalization of $55.44 million and a price-to-earnings ratio of -3.23. The business has a 50 day simple moving average of C$1.94 and a 200-day simple moving average of C$2.72.

Helius Medical Technologies (TSE:HSM) last issued its quarterly earnings results on Tuesday, November 12th. The company reported C($0.29) earnings per share for the quarter, meeting the Zacks’ consensus estimate of C($0.29). The firm had revenue of C$0.20 million during the quarter, compared to the consensus estimate of C$0.40 million.

Helius Medical Technologies Company Profile

Helius Medical Technologies, Inc, a neurotechnology company, focuses on developing, licensing, or acquiring noninvasive technologies for the treatment of symptoms caused by neurological disease or trauma. The company's product is Portable Neuromodulation Stimulator, a medical device in Canada for the treatment of chronic balance deficit associated with a mild to moderate traumatic brain injury.

Featured Story: What is the outlook for the FAANG stocks?

Receive News & Ratings for Helius Medical Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Helius Medical Technologies and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Air Products & Chemicals  Reaches New 1-Year High on Analyst Upgrade
Air Products & Chemicals Reaches New 1-Year High on Analyst Upgrade
Datadog  Stock Price Up 3% Following Analyst Upgrade
Datadog Stock Price Up 3% Following Analyst Upgrade
Helius Medical Technologies Inc  Expected to Earn FY2019 Earnings of  Per Share
Helius Medical Technologies Inc Expected to Earn FY2019 Earnings of Per Share
Splunk  Stock Price Down 6.2% on Insider Selling
Splunk Stock Price Down 6.2% on Insider Selling
SmileDirectClub  Sets New 12-Month Low After Analyst Downgrade
SmileDirectClub Sets New 12-Month Low After Analyst Downgrade
Griffon  Sees Unusually-High Trading Volume on Better-Than-Expected Earnings
Griffon Sees Unusually-High Trading Volume on Better-Than-Expected Earnings


© 2006-2019 Ticker Report